About Us

At Precimmo , we are rethinking how cancer
is diagnosed and treated.

We build practical tools that bring precision medicine

into everyday cancer care.

‘From concept to clinic—where it matters most’

Our focus is early detection, biomarker-based insights,

and personalized therapy guidance.

‘Because the right care starts with the right data’

OncoAdvisor™ is our flagship platform that supports

clinical decision-making.

‘Built for oncologists, shaped by real-world needs’

It helps doctors make timely, informed decisions based

on each patient’s unique cancer profile.

‘Precision made personal’

Our Team

We are scientists, oncologists, engineers, and strategists working together to turn complex cancer data into clear clinical guidance.

Dr. Shoaib Rao

Founder & CEO
PhD. Cancer Biology

Dr. Shoaib Rao

Founder and CEO

PhD. Cancer Biology

Cancer Biologist With Expertise In Translational Oncology. Leads Product Development, Strategy, And Clinical Collaborations Across Key Regions.

Gohar Iqbal

AI Integration
Advisor

Gohar Iqbal

VP Product & AI Integration Lead

Technology Advisor With Experience In AI-Based Platforms And Venture Development. Leads Product Architecture And Integration Of Intelligence Into OncoAdvisor™.

Dr. Tooba I. Baqai

Medical Oncologist & Clinical Integration Lead

Dr. Tooba I. Baqai

Medical Oncologist & Clinical Integration Lead

Practicing Oncologist With Deep Understanding Of NCCN, ASCO, and ESMO Guidelines. Ensures That All Clinical Recommendations Are Grounded In Real-World Practice.

Vishal Shamsi

LL.M., Barrister-at-Law (Lincoln’s Inn), MCIArb
Legal Counsel & Regulatory Compliance Lead

Vishal Shamsi

Legal Counsel & Regulatory Compliance Lead

Advises On Licensing, International Regulatory Submissions, And Ethical Compliance. Supports DRAP, FDA, And CE-IVD Pathways For Diagnostic Approvals.

Rais Kazmi, FIA

Chief Actuary and Health Economics Advisor

Rais Kazmi, FIA

Chief Actuary and Health Economics Advisor

Expert In Rembursement Strategy And Payer Engagement. Supports Cost-Effectiveness Modeling To Ensure Real-World Adoption Of OncoAdvisor™ And Diagnostic Kits.